Jasper Therapeutics: Funding, Investors & Team (Oct 2026)
Jasper is a biotechnology company focused on enabling safer conditioning agents to allow for the expanded use of curative therapy with stem cell transplants and gene therapies. The company s novel engineered hematopoietic stem cells (eHSCs) platform aims to overcome the limitations of transplant grafts while also unlocking the potential of stem cells, potentially increasing the number of patients who could benefit from allogeneic and autologous gene-edited hematopoietic stem cell therapy. Jasper’s lead compound, JSP191, is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing a stem cell transplant.
Jasper Therapeutics has raised $140M across 2 funding rounds on record, the most recent an undisclosed round of $50.0M announced in Feb 2024.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Jasper Therapeutics Company Profile and Key Stats
Latest funding round on record: Feb 2024.
Jasper Therapeutics Funding Rounds
Jasper Therapeutics raised $90.0M in an undisclosed round announced in Jan 2023.
1.1 years later, an undisclosed round of $50.0M was announced in Feb 2024.
Jasper Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Jasper Therapeutics Funding Compared to Other Biotechnology Startups
Jasper Therapeutics' latest round of $50.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Jasper Therapeutics in Biotechnology and Redwood City
Companies Similar to Jasper Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Jasper Therapeutics Funding FAQs
What does Jasper Therapeutics do?
Jasper is a biotechnology company focused on enabling safer conditioning agents to allow for the expanded use of curative therapy with stem cell transplants and gene therapies. The company s novel engineered hematopoietic stem cells (eHSCs) platform aims to overcome the limitations of transplant grafts while also unlocking the potential of stem cells, potentially increasing the number of patients who could benefit from allogeneic and autologous gene-edited hematopoietic stem cell therapy. Jasper’s lead compound, JSP191, is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing a stem cell transplant.
How much funding has Jasper Therapeutics raised?
Jasper Therapeutics has raised $140M across 2 rounds on record. The most recent is an undisclosed round of $50.0M announced in Feb 2024.
When did Jasper Therapeutics last raise funding?
Jasper Therapeutics' most recent funding round on record is an undisclosed round of $50.0M, announced in Feb 2024.
Who founded Jasper Therapeutics?
FundedIQ lists Judith Shizuru Md (Founder), Susan Prohaska (Founder) at Jasper Therapeutics.
Where is Jasper Therapeutics headquartered?
Jasper Therapeutics is based in Redwood City, California, United States.
How many employees does Jasper Therapeutics have?
Jasper Therapeutics is in the 51-100 employee band.
How does Jasper Therapeutics' funding compare to other Biotechnology startups?
Jasper Therapeutics' latest round of $50.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Jasper Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Jasper Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.